United States · FDA National Drug Code directory
Tavaborole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 21922-020_10a126f9-ec1b-44d2-8611-3d6660a53ae8
- Product NDC
- 21922-020
- Form
- SOLUTION
- Composition / generic term
- TAVABOROLE topical solution, 5%
- Labeler
- Encube Ethicals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201019
- Source listing expiry
- 20261231
Source-listed ingredients
- TAVABOROLE — 43.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, WITH APPLICATOR in 1 CARTON (21922-020-12) / 10 mL in 1 BOTTLE, WITH APPLICATOR · 21922-020-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →